Netherlands wet age-related macular degeneration (AMD) market is projected to register a CAGR of 6.3% in the forecast period of 2020 to 2027. The new market report contains data for historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:
Netherlands Wet Age-Related Macular Degeneration (AMD) Market By Drug Class (Monoclonal Antibodies, Benzoporphyrin Derivative, Others), Product (Biologics, Biosimilar), Age Group (60-80 Years, Above 80 Years, 40-59 Years), End User (Hospitals and Clinics, Research and Academic Institutes, Others), Distribution Channel (Hospital Pharmacy, Compound Pharmacy) Market Trends and Forecast to 2027.
Some of the major factors contributing to the growth of the Netherlands wet age-related macular degeneration (AMD) market:

- Increasing prevalence of ageing population
- Appropriate reimbursement scenario of expensive drugs
- Increased research and development activities to develop novel therapies

Market Players:

The key market players for the Netherlands wet age-related macular degeneration (AMD) market are listed below:

- F. Hoffmann-La Roche Ltd
- Regeneron Pharmaceuticals, Inc.
- Allergan
- Alcon Inc.
- Senju Pharmaceutical CO. Ltd.
- Outlook Therapeutics, Inc.
- Coherus Biosciences
- Pfizer Inc.
- Boehringer Ingelheim International GMBH
- Bausch Health
- Novartis AG
- Bayer AG
- Santen Pharmaceuticals Co., Ltd,